Conclusion
Through analysing of off-label prescriptions of tocilizumab in our
hospital, we found most of the indications have scientific evidence to
support. But some indications were supported by low grade scientific
evidence, more studies are required to confirm the clinical values. For
the indication that has no evidence support, we suggest the
administration should strength supervision.